CURIS, INC. Prepaid Expense and Other Assets, Current
CURIS, INC. (CRIS) had Prepaid Expense and Other Assets, Current of $1.11 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.11M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.61M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.85M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.61M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.11M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.61M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.85M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.61M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.53M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $2.21M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $3.04M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $3.10M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.62M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $3.19M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.78M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.08M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.98M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $3.94M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $3.52M 10-K · filed 2024-02-08 | |
| 2022-09-30 | $4.14M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.80M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $3.43M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.27M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $3.09M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.58M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.27M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $1.22M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $2.00M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.31M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $1.06M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $1.62M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $819.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $681.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $827.00K 10-K · filed 2020-03-19 | |
| 2018-09-30 | $1.13M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $776.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $909.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $989.00K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $1.16M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $958.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.22M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.26M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $1.44M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $975.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $928.39K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.20M 10-K · filed 2017-03-09 | $1.20M 10-K · filed 2016-02-29 |
| 2015-09-30 | $818.18K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $777.40K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $828.25K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $489.84K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $655.76K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $363.38K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $501.69K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $495.26K 10-K · filed 2015-02-24 | |
| 2013-09-30 | $505.08K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $413.53K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $398.53K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $390.56K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $498.07K 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $397.14K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $351.33K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $743.80K 10-K · filed 2013-03-13 | |
| 2011-09-30 | $676.00K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $475.07K 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $392.25K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |